Published in Liver Transpl on April 01, 2002
Hepatitis C virus and type 2 diabetes. World J Gastroenterol (2009) 1.57
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl (2011) 1.52
Predictive factors associated with the reversibility of post-transplantation diabetes mellitus following liver transplantation. J Korean Med Sci (2009) 1.40
Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World J Gastroenterol (2012) 1.22
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes (2014) 0.98
Living-donor liver transplantation and hepatitis C. HPB Surg (2013) 0.90
Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis. World J Gastroenterol (2015) 0.80
Metabolic syndrome after liver transplantation: preventable illness or common consequence? World J Gastroenterol (2012) 0.79
Liver transplantation and hepatitis C. Int J Hepatol (2012) 0.79
Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States. BMC Endocr Disord (2003) 0.77
Chronic hepatitis C virus infection and post-liver transplantation diabetes mellitus. World J Gastroenterol (2005) 0.77
HCV in liver transplantation. Semin Immunopathol (2012) 0.76
Clinical features of patients with type 2 diabetes mellitus and hepatitis C infection. Braz J Med Biol Res (2012) 0.76
Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. World J Gastroenterol (2016) 0.75
Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med (2011) 16.93
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med (2013) 8.49
ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis. N Engl J Med (2014) 6.31
Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol (2002) 3.48
Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center. J Clin Oncol (2003) 2.17
Liver injury associated with the beta-interferons for MS: a comparison between the three products. Neurology (2004) 2.16
Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010. Pediatrics (2013) 2.01
Choledochal cysts: part 1 of 3: classification and pathogenesis. Can J Surg (2009) 1.91
Association of direct helicopter versus ground transport and in-hospital mortality in trauma patients: a propensity score analysis. Acad Emerg Med (2011) 1.88
Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007. Liver Int (2008) 1.77
Exploring the psychological effects of deceased organ donation on the families of the organ donors. Clin Transplant (2008) 1.75
Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant (2009) 1.60
Granulomatous hepatitis associated with etanercept therapy. J Rheumatol (2008) 1.56
Severe desflurane hepatotoxicity after colon surgery in an elderly patient. Can J Anaesth (2005) 1.55
Pregnancy and sexual function in liver transplantation. J Hepatol (2008) 1.49
Impact of maternal body mass index on neonate birthweight and body composition. Am J Obstet Gynecol (2008) 1.48
Cross-sectional study of hepatitis B awareness among Chinese and Southeast Asian Canadians in the Vancouver-Richmond community. Can J Gastroenterol (2005) 1.47
Anthropometric Effect of Mucoperiosteal Nostril Floor Reconstruction in Complete Cleft Lip. J Craniofac Surg (2016) 1.40
Spatulated end-to-end bile duct reconstruction in orthotopic liver transplantation. Clin Transplant (2007) 1.39
Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial. Am J Med (2004) 1.34
Epithelioid angiosarcoma of the small bowel. Gastrointest Endosc (2006) 1.26
Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer. Anticancer Drugs (2006) 1.25
Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Transplantation (2007) 1.23
Clozapine-induced fatal fulminant hepatic failure: a case report. Can J Gastroenterol (2009) 1.22
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk Lymphoma (2005) 1.21
Choledochal cysts. Part 3 of 3: management. Can J Surg (2010) 1.21
Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia. Can J Gastroenterol Hepatol (2015) 1.19
Integrating screening and interventions for unhealthy behaviors into primary care practices. Am J Prev Med (2008) 1.18
A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes. Transplantation (2008) 1.18
Gastric polyps in patients with portal hypertension. Eur J Gastroenterol Hepatol (2011) 1.16
Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J Lipid Res (2003) 1.15
Percutaneous liver biopsy practice patterns among Canadian hepatologists. Can J Gastroenterol (2013) 1.15
Comparison of acoustic radiation force impulse imaging (ARFI) to liver biopsy histologic scores in the evaluation of chronic liver disease: A pilot study. Ann Hepatol (2010) 1.14
Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection. J Gastroenterol Hepatol (2012) 1.13
Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway. FEBS Lett (2005) 1.11
Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. Am J Gastroenterol (2009) 1.10
Does this patient with liver disease have cirrhosis? JAMA (2012) 1.09
Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways. Cell Signal (2007) 1.05
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C. Pharmacoeconomics (2003) 1.05
A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients. Ann Hepatol (2012) 1.05
Choledochal cysts: part 2 of 3: Diagnosis. Can J Surg (2009) 1.03
Acute fatty liver of pregnancy. Can J Gastroenterol (2006) 1.03
Obese children have higher arterial elasticity without a difference in endothelial function: the role of body composition. Obesity (Silver Spring) (2011) 1.02
Carbon dioxide insufflation during ERCP for reduction of postprocedure pain: a randomized, double-blind, controlled trial. Gastrointest Endosc (2009) 1.02
Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane. Audiol Neurootol (2010) 1.01
Antibody quantity versus quality after influenza vaccination. Vaccine (2009) 1.01
Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review. Can J Gastroenterol Hepatol (2014) 1.00
Primary hepatic neuroendocrine tumour requiring live donor liver transplantation: case report and concise review. Ann Hepatol (2012) 0.99
Oxidized LDL-mediated macrophage survival involves elongation factor-2 kinase. Arterioscler Thromb Vasc Biol (2008) 0.99
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Liver Int (2005) 0.98
Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl (2005) 0.98
Identification of MMS19 domains with distinct functions in NER and transcription. DNA Repair (Amst) (2006) 0.98
The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report. Transplantation (2007) 0.97
Late acute rejection after liver transplantation: the Western Canada experience. Liver Transpl (2002) 0.96
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C. Hepatology (2008) 0.95
Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking ceramide generation, thereby maintaining protein kinase B activation and Bcl-XL levels. J Biol Chem (2003) 0.94
Predictors of relapse to significant alcohol drinking after liver transplantation. Can J Gastroenterol (2010) 0.94
Blood pressure screening of school children in a multiracial school district: the Healthy Kids Project. Am J Hypertens (2009) 0.94
Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience. Can J Gastroenterol (2008) 0.93
Parvovirus B19 in an immunocompetent adult patient with acute liver failure: an underdiagnosed cause of acute non-A-E viral hepatitis. Can J Gastroenterol (2005) 0.93
MR evidence of long T2 water in pathological white matter. J Magn Reson Imaging (2007) 0.93
Ross operation: 16-year experience. J Thorac Cardiovasc Surg (2008) 0.93
Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance? Dig Dis Sci (2002) 0.93
Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C. World J Gastroenterol (2006) 0.92
Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians. Can J Gastroenterol (2008) 0.91
Review of boceprevir and telaprevir for the treatment of chronic hepatitis C. Can J Gastroenterol (2012) 0.91
Late acute celiac and hepatic artery thrombosis with portal vein thrombosis resulting in hepatic infarction 12 years post orthotopic liver transplantation. Ann Hepatol (2009) 0.91
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients. Ann Hepatol (2011) 0.90
Treatment of chronic hepatitis C in Canadian prison inmates. Can J Gastroenterol (2005) 0.89
Iron overload disorders: treatment options for patients refractory to or intolerant of phlebotomy. Pharmacotherapy (2008) 0.89
Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation. World J Gastroenterol (2009) 0.88
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum (2011) 0.88
Effects of upper extremity exercise training on peak aerobic and anaerobic fitness in patients after transplantation. Am J Cardiol (2004) 0.87
Hepatology and the Canadian gastroenterologist: interest, attitudes and patterns of practice: results of a national survey from the Canadian Association of Gastroenterology. Can J Gastroenterol (2003) 0.87
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients. J Hepatol (2006) 0.87
Factors at the scene of injury associated with air versus ground transport to definitive care in a state with a large rural population. Prehosp Emerg Care (2011) 0.87
SIRPIDs: prevalence and outcome in critically ill patients. J Clin Neurophysiol (2014) 0.86
Retrospective review of pediatric and adult autoimmune hepatitis in two quaternary care centres in British Columbia: increased prevalence seen in British Columbia's First Nations community. Can J Gastroenterol (2007) 0.86
Spontaneous clearance of hepatitis C infection post-liver transplant: A rare but real phenomenon? A case report and review of the literature. Ann Hepatol (2010) 0.86
Evaluation of a community-based participatory physical activity promotion project: effect on cardiovascular disease risk profiles of school employees. BMC Public Health (2010) 0.86
Transient elastography in Canada: Current state and future directions. Can J Gastroenterol Hepatol (2015) 0.85